TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP)

NCT07642297 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Systemic Sclerosis (SSc)
Diffuse Cutaneous Systemic Sclerosis
Skin Fibrosis

Interventions

OTHER: TL1A stimulation and inhibition (in vitro)

Sponsor

Fondazione Policlinico Universitario Campus Bio-Medico

Collaborators

[object Object]